Drug Trial Radar · NCT00329745
Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210)
Last checked: Nov 19, 2026Latest source record: Dec 9, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
8,687
Actual
Start
Jan 2007
Primary completion
Jul 2008
Study completion Jul 2008
Sponsor
- Lead sponsor
- GlaxoSmithKlineGSK (GSK)
- Sponsor type
- Industry
- First posted
- May 25, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 2 years, up to 3 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This Year 3 extension of the main study rota-028, 029 or 030 is conducted to evaluate vaccine efficacy against severe rotavirus (RV) gastroenteritis (GE) during third year of life in infants previously vaccinated with human rotavirus (HRV) vaccine or placebo in the following schedules: at 3 and 4 months of age in study rota-028; at 2 and 4 months of age in study rota-029 or rota-030. The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.
Conditions
- Infections, Rotavirus
Interventions
Rotarix™Biological
Oral administration, 2 doses
PlaceboBiological
Oral administration, 2 doses
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Subjects With Severe Rotavirus Gastroenteritis (RV GE) Caused by the Circulating Wild-type Rotavirus StrainsTime frame: From Year 2 up to Year 3
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
GSK Investigational Site
Singapore, Singapore
GSK Investigational Site
Singapore, Singapore
GSK Investigational Site
Singapore, Singapore
GSK Investigational Site
Singapore, Singapore
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.